Fidelity Investments’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.11M | Sell |
100,756
-14,732
| -13% | -$1.35M | ﹤0.01% | 2078 |
|
|
2025
Q4 | $10.4M | Sell |
115,488
-27,539
| -19% | -$2.61M | ﹤0.01% | 2016 |
|
|
2025
Q3 | $14.1M | Buy |
143,027
+22,668
| +19% | +$2.25M | ﹤0.01% | 1885 |
|
|
2025
Q2 | $11M | Sell |
120,359
-85,719
| -42% | -$8.29M | ﹤0.01% | 1898 |
|
|
2025
Q1 | $23.3M | Sell |
206,078
-1,231,933
| -86% | -$132M | ﹤0.01% | 1627 |
|
|
2024
Q4 | $152M | Buy |
1,438,011
+687,675
| +92% | +$73.8M | 0.01% | 939 |
|
|
2024
Q3 | $81M | Buy |
750,336
+162,384
| +28% | +$17.7M | ﹤0.01% | 1187 |
|
|
2024
Q2 | $63.8M | Sell |
587,952
-198,241
| -25% | -$23.4M | ﹤0.01% | 1218 |
|
|
2024
Q1 | $104M | Sell |
786,193
-266,119
| -25% | -$33.2M | 0.01% | 1044 |
|
|
2023
Q4 | $128M | Sell |
1,052,312
-96,815
| -8% | -$10.8M | 0.01% | 920 |
|
|
2023
Q3 | $129M | Sell |
1,149,127
-31,262
| -3% | -$3.97M | 0.01% | 864 |
|
|
2023
Q2 | $172M | Buy |
1,180,389
+56,137
| +5% | +$7.63M | 0.01% | 776 |
|
|
2023
Q1 | $145M | Buy |
1,124,252
+277,193
| +33% | +$34.8M | 0.01% | 849 |
|
|
2022
Q4 | $108M | Buy |
847,059
+76,936
| +10% | +$8.93M | 0.01% | 942 |
|
|
2022
Q3 | $80.5M | Buy |
770,123
+213,226
| +38% | +$23.4M | 0.01% | 1038 |
|
|
2022
Q2 | $58.5M | Sell |
556,897
-172,751
| -24% | -$20.5M | 0.01% | 1189 |
|
|
2022
Q1 | $93.3M | Sell |
729,648
-2,615
| -0.4% | -$315K | 0.01% | 1096 |
|
|
2021
Q4 | $90.3M | Sell |
732,263
-127,989
| -15% | -$16.8M | 0.01% | 1146 |
|
|
2021
Q3 | $122M | Sell |
860,252
-59,408
| -6% | -$8.74M | 0.01% | 1014 |
|
|
2021
Q2 | $144M | Buy |
919,660
+16,847
| +2% | +$2.73M | 0.01% | 960 |
|
|
2021
Q1 | $140M | Buy |
902,813
+24,987
| +3% | +$3.87M | 0.01% | 938 |
|
|
2020
Q4 | $131M | Buy |
877,826
+7,887
| +0.9% | +$1.11M | 0.01% | 921 |
|
|
2020
Q3 | $115M | Sell |
869,939
-29,266
| -3% | -$3.82M | 0.01% | 846 |
|
|
2020
Q2 | $104M | Sell |
899,205
-402,529
| -31% | -$46.4M | 0.01% | 857 |
|
|
2020
Q1 | $128M | Sell |
1,301,734
-674,252
| -34% | -$88.4M | 0.02% | 671 |
|
|
2019
Q4 | $287M | Buy |
1,975,986
+798,965
| +68% | +$110M | 0.03% | 516 |
|
|
2019
Q3 | $157M | Buy |
1,177,021
+3,591
| +0.3% | +$464K | 0.02% | 707 |
|
|
2019
Q2 | $134M | Sell |
1,173,430
-226,395
| -16% | -$26.5M | 0.02% | 801 |
|
|
2019
Q1 | $174M | Sell |
1,399,825
-328,002
| -19% | -$37.3M | 0.02% | 700 |
|
|
2018
Q4 | $174M | Sell |
1,727,827
-718,086
| -29% | -$80.8M | 0.02% | 636 |
|
|
2018
Q3 | $312M | Sell |
2,445,913
-111,734
| -4% | -$13.3M | 0.04% | 489 |
|
|
2018
Q2 | $277M | Sell |
2,557,647
-392,525
| -13% | -$42.7M | 0.03% | 534 |
|
|
2018
Q1 | $312M | Sell |
2,950,172
-592,246
| -17% | -$68.8M | 0.04% | 499 |
|
|
2017
Q4 | $415M | Sell |
3,542,418
-495,295
| -12% | -$56M | 0.05% | 409 |
|
|
2017
Q3 | $459M | Sell |
4,037,713
-73,230
| -2% | -$8.45M | 0.06% | 359 |
|
|
2017
Q2 | $512M | Sell |
4,110,943
-1,371,460
| -25% | -$163M | 0.06% | 310 |
|
|
2017
Q1 | $650M | Sell |
5,482,403
-1,367,412
| -20% | -$155M | 0.08% | 253 |
|
|
2016
Q4 | $686M | Sell |
6,849,815
-2,025,285
| -23% | -$217M | 0.09% | 233 |
|
|
2016
Q3 | $1.12B | Buy |
8,875,100
+1,420,262
| +19% | +$175M | 0.15% | 137 |
|
|
2016
Q2 | $871M | Buy |
7,454,838
+416,644
| +6% | +$47.2M | 0.12% | 180 |
|
|
2016
Q1 | $729M | Sell |
7,038,194
-88,135
| -1% | -$8.53M | 0.1% | 205 |
|
|
2015
Q4 | $710M | Sell |
7,126,329
-3,724,985
| -34% | -$364M | 0.1% | 218 |
|
|
2015
Q3 | $990M | Sell |
10,851,314
-2,140,552
| -16% | -$215M | 0.14% | 151 |
|
|
2015
Q2 | $1.38B | Sell |
12,991,866
-1,161,295
| -8% | -$128M | 0.18% | 120 |
|
|
2015
Q1 | $1.61B | Buy |
14,153,161
+2,225,769
| +19% | +$254M | 0.21% | 97 |
|
|
2014
Q4 | $1.31B | Buy |
11,927,392
+2,175,476
| +22% | +$229M | 0.17% | 125 |
|
|
2014
Q3 | $952M | Buy |
9,751,916
+3,601,442
| +59% | +$354M | 0.13% | 170 |
|
|
2014
Q2 | $620M | Buy |
6,150,474
+2,732,741
| +80% | +$267M | 0.08% | 276 |
|
|
2014
Q1 | $314M | Buy |
3,417,733
+3,892
| +0.1% | +$359K | 0.04% | 453 |
|
|
2013
Q4 | $309M | Sell |
3,413,841
-43,253
| -1% | -$3.74M | 0.04% | 445 |
|
|
2013
Q3 | $276M | Sell |
3,457,094
-843,570
| -20% | -$66.4M | 0.04% | 483 |
|
|
2013
Q2 | $313M | Buy |
+4,300,664
| New | +$322M | 0.05% | 410 |
|
Other funds holding ZBH
VCM
VPM
Fidelity Investments's ZBH Position: Q1 2026 in Review
Fidelity Investments reduced its Zimmer Biomet (ZBH) stake by 13% in Q1 2026, selling an estimated $1.35M and leaving 100,756 shares worth $9.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2078.
Fidelity Investments first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.61B in Q1 2015. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Fidelity Investments held 100,756 shares of Zimmer Biomet worth $9.11M as of Q1 2026.
- Fidelity Investments sold 14,732 Zimmer Biomet shares in Q1 2026, an estimated $1.35M.
- Zimmer Biomet made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2078 holding.
- Fidelity Investments first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Zimmer Biomet position peaked at $1.61B in Q1 2015.
- 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.